Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

BerGenBio announces clinical data presentations highlighting the activity of its selective AXL inhibitor bemcentinib in Non-Small Cell Lung Cancer

BERGEN, Norway, August 22, 2023 – BerGenBio ASA (OSE: BGBIO), a clinical-stage biopharmaceutical company developing novel, selective AXL kinase inhibitors for severe unmet medical needs, announced today that additional clinical data of bemcentinib in combination with chemotherapy and with immunotherapy in Non-Small Cell Lung Cancer (NSCLC) have been recently published and accepted for presentation at two upcoming international oncology conferences:   · Comprehensive results from the investigator led trial of bemcentininb + docetaxel in previously treated NSCLC patients (Study

Correction in the Notice of Extraordinary General Meeting of Katalysen Ventures AB (publ)

Correction in the Notice of Extraordinary General Meeting of Katalysen Ventures AB (publ), to be held on September 6, at 4:00 PM at the company's premises at Birger Jarlsgatan 22, Stockholm.The correction pertains to: 1. The date by which shareholders should be registered in the share register maintained by Euroclear Sweden AB, which is corrected from August 30, 2023, to August 29, 2023. 2. The date by which shareholders should notify the Company of their intention to attend the meeting, which is corrected from August 30, 2023, to August 31, 2023.

MapsPeople Financial Report Q2 2023

MapsPeople A/S Company Announcement No.  23-2023 Aalborg, August 22, 2023MapsPeople announces 69% YoY growth in ARR  Q2 -2023 Performance Highlights: · ARR increased by tDKK 13,973 in Q2 2023 to tDKK 52,900 (36% QoQ growth) · ARR increased by tDKK 21,627 from Q2 2022 to tDKK 52,900 in Q2 2023 (69% YoY growth) · MapsIndoors accounted for 86% of the growth YoY.  · Recognised Revenue in Q2 2023 is up tDKK 3,023 (39%) to tDKK 10,720 from Q2 2022  · Recognised Revenue for 2023 YTD is up tDKK 4,980 (35%) to tDKK 19,479 compared to the same period 2022. · EBITDA

Bawat Water Technologies AB: BAWAT Announces Q2 Report 2023

Hørsholm, Denmark,August 22, 2023– Bawat Water Technologies AB (BAWAT) today announces its Q2 Report for 2023. The report is available on Bawat’s website (investor.bawat.com) BAWAT is a leading supplier of sustainable ballast water treatment technology and services. BAWAT was listed on Nasdaq First North Premier Growth Market in Stockholm in March 2022.  Highlights Q2 2023 – closed financing round successfully. First long-term service order in BaaS. Order intake in line with guidance and margins are still increasing. · Order intake in the second quarter was SEK 11.21m. · The

BioStock: International specialist congress and upcoming milestones for Chordate Medical

Chordate Medical has once again received the opportunity to present the company’s migraine treatment K.O.S at a scientific congress. This time at the International Headache Congress in Seoul, Korea, on September 14-17. In addition, the investigators in the PM007 study have submitted a manuscript for a scientific article, which CEO Anders Weilandt elaborates on.Read the full article at biostock.se: https://www.biostock.se/en/2023/08/international-specialist-congress-and-upcoming-milestones-for-chordate-medical/ This is a press release from BioStock - Connecting Innovation & Capital.

Notice of extraordinary general meeting in Katalysen Ventures AB (publ)

The shareholders of Katalysen Ventures AB (publ), reg. no. 556729-9812, ("the Company") are hereby invited to the Extraordinary General Meeting on Wednesday, September 6, at 4:00 PM at the Company's premises at Birger Jarlsgatan 22, Stockholm, Sweden. Note that the following is a translation of a Swedish original.Right to Attend the Extraordinary General Meeting Shareholders who wish to participate and vote at the meeting must: · be registered in the share register kept by Euroclear Sweden AB on August 30, 2023, · notify their intention to attend the Extraordinary General Meeting

”Positive results from PK study with cobitolimod” selected as one of the best abstracts for poster presentation at UEGW

August 22, 2023 – InDex Pharmaceuticals Holding AB (publ) today announced that the positive results from the pharmacokinetic (PK) study with cobitolimod in patients with moderate to severe ulcerative colitis will be presented at one of the leading gastroenterology conferences, the United European Gastroenterology Week (UEGW). The abstract was selected as one of the best abstracts for poster presentation and is therefore also chosen to be presented orally in one of the moderated poster sessions.“We are very pleased that our presentation of the PK study results was selected as one of the best

Arctic Bioscience – Invitation to presentation of half year 2023 results

Arctic Bioscience will publish its financial results for the half year 2023 on Tuesday 29[th] of August, at 08:00 CET.The same day at 12:00 CET, the Company will host a webcast to present the results and give an operational update. Following the presentation, it will be opened for questions from the audience. Webcast details: Date: Tuesday 29[th] of August 2023 Time: 12:00 CET Format: Webcast and Q&A Language: English The presentation can be accessed through the Company’s website, or with the link below: Link: https://channel.royalcast.com/hegnarmedia/#!/hegnarmedia/

Minesto completes build and functional testing of sea-bed connection system for the 1.2-Megawatt powerplant Dragon 12

Minesto, leading ocean energy developer, has completed build and functional testing of sea-bed connection system for the 1.2-Megawatt power plant Dragon 12. The unique connection system, enabling one of the fastest launch and recovery operation in marine energy by “one-stab” operation, is now ready for installation.The Dragon 12 connection system is a scale-up and further enhancement of Minesto’s unique and verified LARS (Launch & Recovery System) technology, a principle applied and proven by Minesto since 2020. The system is remotely operated and controlled from the surface vessel by

Here are the summer openings at Arlanda

Over the summer, a number of new outlets have opened at Stockholm Arlanda Airport. And more will be added before the new Marketplace opens its doors in September. Early this summer, the new state-of-the-art security checkpoint in Terminal 5 at Arlanda opened, and many passengers have already experienced it. Immediately adjacent to the security checkpoint, the new Marketplace – the largest commercial investment ever at Arlanda – is now taking shape. The Marketplace will feature Nordic design and have a total of 11,000 square metres of commercial space. The first shops and restaurants will

Notification of managers’ and closely related parties’ transactions with Dampskibsselskabet NORDEN A/S’ shares in connection with share buy-back program

ANNOUNCEMENT NO. 122 - 22 AUGUST 2023   In connection with the announced share buy-back program in NORDEN, A/S Motortramp continuously sells shares pro rata and the market is to be informed accordingly – see the attached file and announcements nos. 112/23 and 113/23.   Kind regards, Dampskibsselskabet NORDEN A/S   Martin Badsted CFO     For further information: Stig Frederiksen, Head of Investor Relations, tel.: +45 32 71 08 55, e-mail: sfr@norden.com

Heart Aerospace joins Regional Airline Association

Swedish electric airplane maker Heart Aerospace joins the Regional Airline Association (RAA), a trade association for North American regional airlines and associated businesses.As the leading trade body for the North American regional market, the RAA’s connections and relationships with policy makers will give Heart Aerospace a unique insight and ability to help shape the evolving government policy discussions on battery electric flight.  North Amercian regional carriers provide essential connectivity to the regions and the ES-30 is uniquely placed to both reopen lost air markets as well

Elkem ASA – Fixed income global investor call and contemplated NOK green bond issuance

Oslo, 22 August 2023 Elkem ASA, rated BBB (stable) by Scope, has mandated Danske Bank and DNB Markets as Joint Lead Managers and Green Bond Advisors to arrange a fixed income global investor call on 23 August 2023. One or more NOK-denominated senior unsecured green bond issues with a minimum tenor of three years and volume up to NOK 1 billion in total may follow, subject to inter alia market conditions. The proceeds from the contemplated green bond issuance will be used in accordance with the newly established green bond framework, which has obtained a second party opinion from S&P

Ework Group signs a four-year framework agreement with Sykehusinnkjøp in Norway

Ework Group Norway AS signs a new framework agreement with Sykehusinnkjøp in Norway, the professional purchasing service for Norwegian specialist healthcare. The agreement runs over four years, and covers provision of specialists in several skill areas, such as project management, system development and information security. Ework was one of the few tenders selected in eight of a total of ten subcontracts.“We are pleased to renew our contract, as it allows us to continue delivering the skills and talents required by the healthcare sector in Norway. Ework Group has since 2017 been a strong

OrderYOYO A/S publishes first half-year report 2023 confirming earlier announced ARR growth of 47% to DKK 246m and H1 2023 EBITDA of DKK 9m.

OrderYOYO was Cash EBITDA positive in June 2023 – an important and significant milestone!Company Announcement No. 63 - 2023 OrderYOYO A/SInside Information Copenhagen, August 22, 2023 Highlights Strong performance in both Q1 and Q2 2023 with June ARR of DKK 246m, growing 47% compared to June 2022. Despite difficult market conditions, OrderYOYO has continued taking market share in all major markets H1 2023 EBITDA of DKK 9.0m with all months in H1 2023 being EBITDA positive – an improvement of DKK 15.0m compared to H1 2022 EBITDA loss of DKK (6.0)m June was the first month

AMSC ASA - SALE OF THE U.S. JONES ACT ACTIVITIES TO A FUND MANAGED BY MARITIME PARTNERS, LLC

Lysaker, August 22, 2023 – Reference is made to the joint announcement made by AMSC ASA (“AMSC”) and Maritime Partners, LLC. (“Maritime Partners”) today regarding the signing by AMSC and Project Merchant Acquisition LLC (the “PM Acquisition”), a newly-formed company owned and controlled by a fund managed by Maritime Partners, of a share purchase agreement (the “SPA”) for PM Acquisition’s purchase of American Tanker Holding Company, Inc. (“ATHC”), a wholly-owned subsidiary of AMSC (the “Transaction”). Pål Lothe Magnussen, CEO of AMSC commented that “the management team at AMSC is pleased

AMSC ASA - FUNDS MANAGED BY MARITIME PARTNERS, LLC AGREES TO ACQUIRE U.S. JONES ACT BUSINESS OF AMSC ASA

LYSAKER, NORWAY AND NEW ORLEANS, LOUISIANA (August 22, 2023) - AMSC ASA (“AMSC”) and Maritime Partners, LLC today announced that AMSC and Project Merchant Acquisition LLC (the “PM Acquisition”), a newly-formed company owned and controlled by a fund managed by Maritime Partners, LLC, have signed a share purchase agreement (the “SPA”) for PM Acquisition’s purchase of American Tanker Holding Company, Inc. (the “ATHC”), a wholly-owned subsidiary of AMSC, (the “Transaction”). ATHC, through its subsidiaries, owns nine handysize products tankers and one handysize shuttle tanker, all of which are

Brain+ Online Investor Update

Copenhagen, Denmark, May 22, 2023 – Brain+ A/S (Nasdaq First North: BRAINP)On Friday 01 September 2023 at 16:00 CEST, Brain+ will host an online Investor Update. The Investor Update will start with a presentation from the CEO, Kim Baden-Kristensen followed by a Q&A session where the CEO will answer questions from investors. Brain+ invites all interested, both current investors and potential investors to participate in this event, ask questions directly before the event starts, and upvote those questions you would like addressed. The Q&A is already open, meaning that you can already now

Realheart to Present at Three Scientific Conferences in Europe

Press Release August 22, 2023  Realheart will be presenting its research results at three different scientific conferences in Europe over the next month – the ESAO in Bergamo, the BDW in Rostock and the EUMS in Paris – where many future customers and partners will also be attending. At ESAO, the company will highlight its experiences with animal-free methods and challenge the industry to take the step away from animals.The annual conference of the European Society for Artificial Organs , which this time takes place in Bergamo, Italy, between 29 August and 1

Invitation to NYAB Plc's webcast on the half-yearly report

NYAB PlcINVESTOR NEWS22 August 2023 at 09:30 Invitation to NYAB Plc's webcast on the half-yearly report NYAB Plc will publish its half-yearly report for period 1 January - 30 June 2023 on Friday, 25 August 2023. On the same day at 14:00 EET, the company will arrange a webcast in which CEO Johan Larsson and CFO Aku Väliaho will present NYAB’s financial information and significant events for the first half of the year. The webcast will be held in English. However, participants can ask questions via the event chat room in both Finnish and English. Registration for the webcast

Interim report April – June 2023

Second quarter in brief · Net sales amounted to 21.2 million SEK (18.7), which means a sales growth of 13 percent.  · Operating profit amounted to 2.8 million SEK (4.4).  · Net profit for the period amounted to 3.6 million SEK (4.7).  · Earnings per share amounted to 0.09 SEK (0.12).  First half year in brief · Net sales for the first half year amounted to 37.4 million SEK (28.6), which means a sales growth of 31 percent.  · Operating profit amounted to 0.8 million SEK (0.8).  · Profit for the period amounted to 1.3 million SEK (1.3).  · Earnings

Portfolio Update - Bright Ascension Limited

Capital for Colleagues plc / EPIC: CFCP / Market: AQSE / Sector: Financials   22 August 2023 CAPITAL FOR COLLEAGUES PLC (‘Capital for Colleagues’, ‘C4C’ or the ‘Company’)   PORTFOLIO UPDATE – BRIGHT ASCENSION LIMITED   Capital for Colleagues, the investment vehicle focused on opportunities in the Employee Owned Business (‘EOB’) sector, is pleased to announce a further update in respect of its investee company, Bright Ascension Limited (‘BAL’).   BAL is an industry-leading space-software technology provider, offering unique off-the-shelf software products and

GomSpace (provider of nanosatellites) announces its quarterly results for the second quarter 2023

Stockholm, August 22, 2023. GomSpace Group AB (the “Company”) announces its interim report for the second quarter of 2022. The report is available on the Company’s homepage (www.gomspace.com). The following is taken from the quarterly report:Second quarter summary 1 April – 30 June 2023 (2022) · Order intake was T.SEK 22,671 (43,931) · Net revenues slightly decreased by 2% to T.SEK 50,275 (51,253) · Gross margin decreased to negative 30% (positive 6%) due to a revenue mix with less profitable engineering projects and one-off costs due to terminated unprofitable engineering

DDM Holding AG and DDM Debt AB to report second quarter and half year 2023

DDM Holding AG (First North Growth Market: DDM) and its subsidiary DDM Debt AB (Nasdaq Stockholm: DDM Debt 2026) will publish their Q2 and half year 2023 reports on Tuesday 29 August 2023 at 08:00 CEST. Mr. Razvan Munteanu, CEO, and Mr. Fredrik Olsson, CFO, will host a conference call the same day, beginning at 10:00 CEST, to present and comment on the DDM Group’s financial results. The conference will be held in English and can be followed live on www.ddm-group.ch  or via teleconference with prior registration at: https://

There are no items matching the current filter
There are no more items matching the current filter
Back to top